Business
Accuray Announces Agreement with Brainlab to Expand CyberKnife® Platform Treatment Capabilities for the Neuro-Radiosurgery Market
Interoperability between Brainlab and Accuray planning systems using Snke OS, an enterprise health tech platform SUNNYVALE, Calif., Oct. 28, 2020 /PRNewswire/
About this update from Accuray Incorporated
[{"type":"text","content":"Interoperability between Brainlab and Accuray planning systems using Snke OS, an enterprise health tech platform\n\n\nSUNNYVALE, Calif., Oct. 28, 2020 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY), a pioneer in the robotic stereotactic radiosurgery (SRS) field announced today a collaboration with Brainlab, a Munich, Germany based market leader in digital surgery and precision radiotherapy that will enhance and expand the Accuray CyberKnife® treatment platform for the neuro-radiosurgery market. The two companies are partnering to provide the neuro-radiosurgery community with access to Brainlab Elements planning software, which will provide contouring capabilities optimized for neurosurgeons. The partners will further strive to leverage interoperability with Snke OS, the Brainlab health tech platform to ultimately improve the experience of those administering and receiving radiation treatments. This interoperability will also allow customers to add CyberKnife treatment data via Quentry, the Brainlab patient registry platform, and enable their participation in neuro-radiosurgery patient registries to help improve patient outcomes.\n\n \n \n \n \n \n \n\n \nSnke OS is the platform from Brainlab that creates the linkage between data sources, driving comprehensive insights and analytics with the aim to improve health tech and best practices. The software delivers on the broader goal to create comprehensive digital patient models that are continuously updated and managed along the patient journey. Integration and aggregation of the patient models in the cloud-based version of Snke OS allows for systematic analysis and lays the foundation for digital clinical research. The platform is being designed to facilitate adaptive radiotherapy workflows by enabling rapid re-planning based on dynamic updates of the digital patient model.\nThe CyberKnife S7TM System is a robotic, non-invasive radiation therapy device that offers a highly precise treatment for cancerous and benign tumors throughout the body, as well as functional neurologic/movement disorders. It is routinely used to treat conditions in the brain while minimizing dose to brain tissues involved in important functions such as hearing and vision. The CyberKnife System combines state-of-the-art robotic architecture with fully integrated image guidance and continual, delivery adap...